Instadose Pharma Corp.
INSD
$0.00
$0.000.00%
OTC PK
| 02/28/2022 | 02/28/2021 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.20K | -- | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 66.20K | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 70.40K | -- | |||
|
|
|||||
| Total Current Assets | 70.40K | -- | |||
| Net Property, Plant & Equipment | 3.16M | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | 31.59M | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 1.37M | -- | |||
| Total Assets | 36.26M | -- | |||
|
|
|||||
| Total Accounts Payable | 3.95M | -- | |||
| Total Accrued Expenses | 3.35M | -- | |||
| Short-term Debt | 40.90K | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 81.80K | -- | |||
| Total Finance Division Other Current Liabilities | 631.40K | -- | |||
| Total Other Current Liabilities | 631.40K | -- | |||
| Total Current Liabilities | 8.05M | -- | |||
|
|
|||||
| Total Current Liabilities | 8.05M | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | 40.90K | -- | |||
| Capital Leases | 64.70K | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 8.11M | -- | |||
|
|
|||||
| Common Stock & APIC | 164.46M | -- | |||
| Retained Earnings | -136.32M | -- | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | 28.14M | -- | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | 28.14M | -- | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 28.14M | -- | |||
|
|
|||||